To report a case of decreased best spectacle-corrected visual acuity (BSCVA) 2 months after Intacs implantation.
A number of studies have been published with different Intacs confi gurations: single, double, asymmetrical, symmetrical, thicker above, and thicker below. Most studies report an improvement in best spectacle-corrected visual acuity (BSCVA) in the majority of patients but the degree to which this occurs is highly variable. Part of the problem is an imperfect understanding of corneal and Intacs biomechanics. Our own experience and the results of our published study 1 have led us to believe that a single segment thicker Intacs placed below produces the best results for peripheral or paracentral cones. We present a patient who had a reduction in BSCVA as a result of undergoing double asymmetrical Intacs insertion with the thicker segment above.
CASE REPORT
A 33-year-old woman was evaluated at an outside institution for consideration of Intacs (Addition Technology, Des Plaines, Ill) implantation. She was diagnosed with keratoconus 5 years previously and had been wearing gas permeable contact lenses since. Her father also had keratoconus. For 2 years she experienced increasing contact lens intolerance, and the lenses would fall out of her eyes on a regular basis. Artifi cial tears were not helpful. Because the patient had an active lifestyle, she found her symptoms to be disturbing. Her health was good and she was taking no medications.
Manifest refraction on initial examination was Ϫ6.75 ϩ1.25 ϫ 130, with BSCVA of 20/20 in the right eye and Ϫ8.75 ϩ1.50 ϫ 130 with BSCVA of 20/20 in the left eye. Central corneal thickness readings were 494 and 493 µm in the right and left eyes, respectively. Pupil size was 5.9 mm and 6.1 mm in the right and left eyes, respectively. Corneal topography showed paracentral cones in both eyes, displaced inferiorly with steepest Ks of 47.50 diopters (D) at 114° and 47.90 D at 104° (right and left eyes, respectively). Slit-lamp examination showed mildly ectatic corneas with no scarring. Fundus examination was normal. Because the left eye was dominant, Intacs implantation was planned for this eye.
The surgical technique consisted of making an incision in the 130° axis of astigmatism based on manifest refraction. Incision depth was 70% and a mechanical dissector was used to create the channels. Asymmetric segments were inserted-0.35 mm superiorly and 0.25 mm inferiorly. The technique of placing the thicker segment superiorly and thinner segment inferiorly has been described previously by other surgeons and is based on the theory that it will shift the cone centrally towards the optical center. A single suture was placed at the incision site.
Two months postoperatively, the patient presented to our practice with deteriorating vision in the left eye. She had not been fi tted with a soft contact lens in the interim. Manifest refraction was Ϫ8.50 ϩ2.50 ϫ 79 yielding 20/30, representing a loss of 2 lines of BSCVA. Slitlamp examination revealed a loose suture and healed double Intacs segments. Corneal topography showed an inferior paracentral cone (Fig 1) .
Our proposed mechanism for loss of BSCVA was that the thicker superior segment caused excessive fl attening above the cone (an area relatively fl atter preoperatively). We explanted the 0.35-mm superior segment, Reports and the 0.25-mm inferior segment was exchanged for a 0.35-mm segment. The Intacs procedure was combined with corneal collagen cross-linking with ribofl avin (C3-R) on the same day, as we have found this to augment fl attening by the Intacs (Chan CK, Sharma M, Boxer Wachler BS, unpublished data, 2005). These procedures led to a marked topographic and refractive improvement (see Fig 1) at 3 months postoperatively. The manifest refraction was Ϫ5.25 ϩ0.75 ϫ 150, which returned BSCVA to 20/20. The difference map (see Fig  1) shows resolution of induced astigmatism. The patient was fi tted with a soft contact lens and is satisfi ed with the result.
DISCUSSION
In the United States, Intacs have been used for keratoconus since 1999 but controversy remains regarding the best technique for placement of segments. It has been our experience that a single segment works best for paracentral and peripheral cones, whereas a symmetrical double segment works best for central cones. 1 Our theory is that in peripheral keratoconus, the cone is oriented around a meridian of astigmatism, and there is a relatively steep area below the meridian and a relatively fl at area above (Fig 2) . Placement of a segment above the meridian in the fl at topographic area exacerbates the topographic power asymmetry by causing further fl attening. We have observed a unique coupling effect with implantation of a single Intacs segment in that superior steepening occurs, which improves corneal symmetry (see Fig 2) . We describe this to our patients as a "beanbag effect"; that is, sitting on or fl attening one end of the beanbag results in the other end popping up. Alio et al 2 recently demonstrated that using a single segment for inferior keratoconus and a double segment for keratoconus, which extends above the 180° axis, is effective.
We have also found that C3-R augments the effect of inferior segment Intacs (Chan CK, Sharma M, Boxer Wachler BS, unpublished data, 2005). Wollensak et al 3 demonstrated that fl attening occurs with collagen cross-linking alone. We believe the primary reason for our patient's improvement in BSCVA and corneal shape was the Intacs exchange, but C3-R may have added to the topographic and refractive improvements, along with the superior segment explantation.
The idea of using a thinner segment under the cone and a thicker one above to displace the cone towards the optical center is an intriguing idea. Asymmetrical segments in the opposite confi guration (thicker segment below cone and thinner segment above cone) have been used previously and have shown to be effective. [4] [5] [6] To our knowledge, the results of the technique used in this report (thicker segment above cone and thinner segment below cone) have not been published in the literature.
In our patient, prior placement of a thicker segment above the cone resulted in loss of BSCVA and increase in manifest cylinder. Alio et al 7 recently reported another case where this approach resulted in loss of BSCVA and increased keratometric values, which was subsequently remedied by exchanging the two segments. There are a number of possible reasons why this technique may not produce optimal results: 1) shifting the cone centrally will shift an irregular part of the cornea into the visual axis. If the cone was a symmetrical sphere, this would have the effect of inducing myopia, but as it is an irregular shape, it will likely worsen distortions; and 2) the topography of a cone has two areas-a steep area below and a fl at area above. Placing a segment in the upper half will further fl atten an already fl at area. Placing the thicker segment will fl atten it further still and heighten the asymmetry. E xcimer laser photorefractive keratectomy (PRK) is a popular refractive procedure proven to be effective and safe for the correction of refractive errors. 1 However, postoperative corneal subepithelial scarring is a challenging complication following PRK, especially after high myopic corrections. 2 Stromal wound healing modulators have been used to minimize corneal haze formation, but limited effi cacy is reported. 3, 4 Topical mitomycin C (MMC) was recently introduced as an adjunctive therapy for the treatment of corneal haze after PRK. 5, 6 We describe a 40-year-old patient who underwent repeat PRK with MMC application to treat corneal haze formation following previous PRK in one eye, and MMC to prevent corneal haze after PRK in the contralateral eye, which resulted in different outcomes.
CASE REPORT
A 40-year-old woman presented at the Cole Eye Institute, Cleveland, Ohio for refractive surgery to correct manifest refractive error of Ϫ8.00 ϩ2.50 ϫ 89 and Ϫ8.75 ϩ1.75 ϫ 91 in the right and left eyes, respectively. Best spectacle-corrected visual acuity (BSCVA) was 20/20 in both eyes. Cycloplegic refraction was Ϫ7.50 ϩ2.50 ϫ 92 in the right eye and Ϫ8.25 ϩ2.00 ϫ 90 in the left eye. Preoperative keratometric readings were 43.25/45.12 @ 04 in the right eye and 43.00/44.75 @ 180 in the left eye. Ultrasonic pachymetry showed central corneal thickness of 545 µm in the right eye and 551 µm in the left eye. Corneal topography was normal in both eyes. Colvard infrared pupillometer (Oasis Medical, Glendora, Calif) showed pupil size of 5.2 mm in the right eye and 5.0 mm in the left eye. All preoperative tests were normal and there was no signifi cant medical or ocular history. However, slit-lamp examination revealed anterior basement membrane dystrophy in both eyes.
The patient underwent uneventful PRK for distance correction in the left eye with the LADARVision 4000 (Alcon Laboratories Inc, Ft Worth, Tex) in January 2002. Alcohol removal of epithelium was completed and stromal photoablation was performed using a 6.0-mm optical zone with ablation depth of 96 µm. Postoperatively, the patient was treated with prednisolone acetate 1% (Predforte; Allergan, Irvine, Calif), ketorolac tromethamine 0.5% (Acular, Allergan), and ciprofl oxacin 0.3% (Ciloxan, Alcon Laboratories Inc) four times a day and a bandage contact lens (Sofl ens 66; Bausch & Lomb, Rochester, NY) was applied. The epithelial defect healed in 5 days and the bandage contact lens was removed. Ciloxan and Acular were discontinued 1 week postoperatively and Predforte was tapered over the next 3 weeks.
Two weeks after surgery, uncorrected visual acuity (UCVA) and BSCVA was 20/30 and 20/20, respectively, with residual refractive error of ϩ0.50 ϩ0.25 ϫ 165. Four weeks after PRK, the patient developed central subepithelial corneal haze (3ϩ/4ϩ) and BSCVA was 20/30 with manifest refraction of Ϫ1.25 ϩ0.50 ϫ 175. Refractive error stabilized after 5 months, and the patient's left eye was surgically enhanced with PRK and an MMC 0.02%-soaked corneal sponge was applied intraoperatively for 2 minutes, followed by copious irrigation with balanced salt solution. The previ-Reports ous postoperative regimen was followed and 3 months after enhancement UCVA and BSCVA improved to 20/25, with a manifest refraction of Ϫ0.50 ϩ0.50 ϫ 155. However, the patient reported persistent symptoms of "cloudiness" due to mild residual central corneal haze in the left eye (Fig) .
The right eye was treated for distance correction 4 months after the left eye with PRK and intraoperative application of MMC 0.02% for 2 minutes due to the increased risk of haze development. The postoperative regimen was the same as the contralateral eye and 2 weeks after the procedure BSCVA in the right eye was 20/20 with a manifest refraction of Ϫ0.75 ϩ0.50 ϫ 95. Three months after surgery, UCVA was 20/20 with residual refractive error of Ϫ0.50 ϩ0.50 ϫ 85, no haze visible on slit-lamp examination, and no postoperative symptoms in the right eye.
DISCUSSION
Mitomycin C is a systemic chemotherapeutic agent, which is useful in ophthalmology. In some cases, topical application of MMC improved results of glaucoma surgery, pterygium excision, and treatment of conjunctival and corneal intraepithelial neoplasia. 7, 8 Mitomycin C creates a potent cytostatic effect, blocking DNA and RNA replication and protein synthesis. As a consequence, MMC may inhibit cell mitosis, proliferation of corneal epithelial, stromal, and endothelial cells, conjunctival cells, and Tenon's capsule fi broblasts. [9] [10] [11] Previous studies have reported good results with PRK and MMC application in preventing and treating corneal haze. 5, 6 Majmudar et al 5 described the effectiveness of MMC 0.02% in treating corneal subepithelial fi brosis after debridement in fi ve patients who underwent previous corneal refractive surgery. In addition, Vigo et al 6 reported signifi cant improvement in corneal transparency in 31 eyes with preoperative haze when treated with MMC 0.02% solution for 2 minutes in association with a stromal scraping procedure. Good outcomes were also reported with prophylactic use of MMC. Carones et al 12 reported decrease in haze formation and more accurate refractive outcomes after prophylactic use of MMC 0.02% with PRK in 60 patients with spherical equivalent correction between Ϫ6.00 and Ϫ10.00 diopters.
To date, no controlled study has been performed comparing the effi cacy of topical MMC in treating and preventing corneal haze formation after refractive procedures. It is hypothesized that, due to its antimitotic properties, MMC inhibits fi broblast proliferation and differentiation, consequently blocking myofi broblast formation, which is the phenotype of the main keratocyte responsible for corneal haze. 13 Topical application of MMC has proven to block fi broblast replication in conjunctival tissue. 9 Additional evidence suggests that topical MMC induces keratocyte apoptosis and may also lead to myofibroblast death by inducing apoptosis and necrosis.
14 Both mechanisms play a combined role, but in the presence of previously existing corneal opacifi cation MMC may not completely eliminate haze due to an eventual persistence of myofi broblast cells. Maldonado 15 reported the presence of residual haze in the center of corneas treated with topical MMC for subepithelial scarring following PRK. It is possible that the antimitotic effect of MMC, which blocks the formation of myofi broblasts and consequently prevents corneal opacifi cation, is clinically more relevant than its cytotoxic effect inducing myofibroblast apoptosis and eliminating previous haze.
Possible toxic side effects are suspected as a consequence of MMC action on corneal tissue, possibly leading to endothelial and stromal complications. Chang 16 recently reported early endothelial edema following a single application of MMC in a rabbit model. In addition, Kim et al 17 described the importance of keratocyte death following PRK with MMC in an animal model, secondary to the apoptotic effect on the stromal keratocytes. No human complications have been reported, but long-term follow-up is required to establish its complete safety. Further studies are necessary to defi nitively describe the mechanisms of MMC on the cornea.
This report does not make a defi nitive conclusion, and additional studies are necessary to fully understand the mechanism of MMC action on corneal tissue, as well as its benefi ts, limitations, and possible side effects. However, clinical outcome does suggest a higher effi cacy of MMC in preventing corneal haze than in treating previous corneal opacifi cation. It is possible that MMC works more effi ciently in blocking fi broblast Reports replication, thereby avoiding their formation, than in eliminating previously formed myofi broblasts, especially among cells located more posteriorly in the stroma. Our fi ndings are consistent with preliminary results of a randomized experimental study performed in rabbits comparing the effi cacy of topical MMC in preventing corneal haze formation versus treatment of previous corneal haze. 18 RESULTS: Patient 1, a 47-year-old man, developed corneal ectasia in his right eye 6 months after unilateral hyperopic LASIK. Preoperative manifest refraction was ϩ2.00 ϩ1.50 ϫ 178 in the right eye and ϩ1.00 sphere in the left eye. Corneal thickness was 585 µm and 575 µm (right and left eye, respectively). Preoperative topography of the right eye demonstrated inferior steepening in the far periphery, suggestive of early pellucid marginal corneal degeneration. Patient 2, a 35-year-old man, developed corneal ectasia in his right eye Ͼ3 years after bilateral LASIK. Preoperative manifest refraction was ϩ2.50 sphere and ϩ3.25 sphere (right and left eye, respectively), and corneal thickness was 556 µm in both eyes. Preoperative topography was normal in both eyes with no evidence of asymmetry, steepening, or irregularity. C orneal ectasia after myopic LASIK was fi rst reported in 1998 and has been well documented in the literature. [1] [2] [3] [4] Identifi ed risk factors include high myopia, low preoperative corneal thickness, low residual stromal bed thickness, and abnormal topographies, including forme fruste keratoconus 3, 4 and pellucid marginal corneal degeneration. 5, 6 This is the fi rst report in the literature of corneal ectasia occurring after hyperopic LASIK. Two cases of ectasia after hyperopic LASIK are presented: one case occurred in a patient with no recognized risk factors, and the other occurred in a patient with topographic fi ndings of pellucid marginal corneal degeneration.
CASE REPORTS PATIENT 1
A 52-year-old man presented in 2005 requesting surgical correction of the refractive error in his right eye following LASIK, which had been performed 5 years previously at an outside facility. Preoperative best spectacle-corrected visual acuity (BSCVA) was 20/20 in both eyes with a manifest refraction of ϩ2.00 ϩ1.50 ϫ 178 in the right eye and ϩ1.00 sphere in the left eye. Corneal thickness was 585 µm and 575 µm (right and left eye, respectively). Preoperative corneal topography in the right eye demonstrated superior fl attening and inferior steepening in the far periphery (Fig 1) . The remainder of Six months postoperatively, the patient complained of blurred vision in the right eye. Uncorrected visual acuity (UCVA) was 20/70, BSCVA was 20/25 with a manifest refraction of Ϫ0.25 ϩ3.25 ϫ 006, and topography showed signifi cantly increased inferior corneal steepening (Fig 2) . The patient was diagnosed with corneal ectasia after LASIK in 2002 and fi tted with a rigid gas permeable contact lens in the right eye.
The patient fi rst presented to our institution in October 2005 seeking alternatives to the contact lens correction of his right eye. At this time, BSCVA was 20/80 in the right eye with a manifest refraction of Ϫ8.00 ϩ7.75 ϫ 140. Central corneal thickness measured 532 µm and 573 µm (right and left eye, respectively) by ultrasound pachymeter. Topography demonstrated advanced corneal steepening in the right eye, and was normal in the unoperated left eye (Fig 3) . Confocal microscopy revealed a fl ap thickness of 154 µm and a residual stromal bed of 290 µm at the thinnest point inferonasally. The patient was informed of the fi ndings and elected to continue wearing the rigid gas permeable contact lens.
PATIENT 2
A 35-year-old man presented for refractive surgery evaluation in June 2000 at an outside facility. Preop- Reports erative BSCVA was 20/15 in both eyes with a manifest refraction of ϩ2.50 sphere in the right eye and ϩ3.25 sphere in the left eye. Corneal thickness was 556 µm in both eyes. Preoperative topography was normal bilaterally with no evidence of asymmetry, steepening, or irregularity (Fig 4) . Topography demonstrated increased inferior steepening (Fig 6) . During the past year, visual acuity has continued to decline, rigid gas permeable contact lens fi tting has been unsuccessful, and the patient is considering penetrating keratoplasty.
DISCUSSION
Corneal ectasia after myopic LASIK has been well described in the literature [1] [2] [3] [4] ; however, to our knowledge, the two cases described represent the fi rst report of ectasia after hyperopic LASIK. The fi rst patient displayed subtle evidence of pellucid marginal corneal degeneration preoperatively, but the second patient had no apparent preoperative risk factors. Whereas most reported ectasia cases have recognizable preoperative risk factors, ectasia developing after myopic LASIK in patients without apparent risk factors has been reported. 7, 8 Pellucid marginal corneal degeneration is an ectatic disorder, typically characterized by bilateral inferior thinning and against-the-rule corneal astigmatism. 9, 10 Classic topographic features of pellucid marginal corneal degeneration include superior fl attening with rapid increase in corneal power inferiorly, with the greatest steepening in the far periphery between 4 o'clock and 8 o'clock. 11 Although this patient exhibited topographic changes suggestive of early pellucid marginal corneal degeneration, manifest refraction in the affected eye was hyperopic with only 1.50 D of astigmatism. The majority of patients with pellucid marginal corneal degeneration have myopia and Ͼ5.00 D of astigmatism. 10, 12 Corneal ectasia has been reported following LASIK in individuals with pellucid marginal corneal degeneration preoperatively 6, 13 ; however, all of these patients had signifi cant myopic refractions, and most had at least 3.00 D of astigmatism. Ambrosio and Wilson 5 also reported two cases of patients presenting for refractive surgery evaluation with early pellucid marginal corneal degeneration. Both cases had myopic astigmatism and more pronounced topographic changes than our case.
In a recent review by Sridhar et al, 10 all reported cases of pellucid marginal corneal degeneration had topographic evidence of bilateral disease. In contrast, the patient in our report had no obvious evidence of pellucid marginal corneal degeneration in the non-operated eye, with a normal keratometric map and spherical refraction; however, inferior corneal thickness as measured by the Orbscan II (Bausch & Lomb Inc, Salt Lake City, Utah) was only 5 µm thicker than central thickness (570 µm centrally and 575 µm inferiorly). In normal subjects, average inferior corneal thickness measurements are more than 60 µm thicker than average central corneal thickness measurements.
14 With hyperopic LASIK, central corneal steepening occurs as a result of peripheral corneal ablation. Thus, in patients with pellucid marginal corneal degeneration, treatment of hyperopia results in tissue removal at the thinnest, weakest portion of the peripheral cornea.
Corneal ectasia can occur after hyperopic LASIK in patients with or without apparent preoperative risk factors. Although rare, patients with pellucid marginal corneal degeneration can present with subtle topographic changes and hyperopic refractive errors. These individuals are at increased risk for corneal ectasia after LASIK. not possible to identify the reason for the procedure's refractive failure, as technical problems with the settings of the laser machine were not obvious. With the refractive effect absent, no evidence was found for resulting ocular problems. Weeks later, a second LASIK procedure was performed following a re-lift of the initial corneal fl ap. Again, it did not yield a relevant refractive change. Because the refractive effect was unsatisfactory, the corneal fl ap was re-lifted once more and an intracorneal lens (PermaVision, Anamed Inc) was implanted. After re-lifting the fl ap with a round microspatula, the bed was rinsed with 0.9% sodium chloride and the device laid onto the corneal stromal surface within the bed by sliding sidewards from the specially provided spoon. Centration was secured by subjective medial position relative to the patient's miotic pupil to align the optical center of the lens with the optical axis of the eye. Finally, the fl ap was laid back onto the stromal surface and fl attened over the bed with the lens. Decentration of the intracorneal lens occurred 1 week postoperatively, which necessitated re-lifting of the fl ap a third time to reposition the lens.
After implantation of the intracorneal lens, the patient complained of an increasingly burning ache in the eye with decreased visual acuity. Three weeks after implantation, best spectacle-corrected visual acuity (BSCVA) was 2/10 and objective refraction was ϩ3.25 D, thus unaltered from starting values. Slit-lamp examination revealed marked delineation of the superfi cial fl ap with grayish contours. Epithelial ingrowth islets were detected covering approximately one-eighth of the entire fl ap area, concentrated in the lenticular periphery. In addition, regionally condensed hazy opacity was noted, particularly in the inferior hemisphere, with the implant decentered superionasally (Fig) . Corneal topography revealed central depression. Refraction was Ϫ2.00 Ϫ1.00 ϫ 65°. Because topical steroid administration over 4 weeks did not alleviate symptoms, the lens was removed. The fl ap was lifted with a blunt spatula without encountering major tissue resistance at the peripheral circumference. The lens was explanted from the stromal bed with forceps and the interface was carefully polished using a sharp, hockey knife followed by 0.9% sodium chloride rinsing. This was done to remove debris and epithelial cells evident under the slit-lamp microscope. The fl ap was then rolled back and correct position secured by application of a bandage contact lens for 48 hours.
Twenty weeks postoperatively, the patient recovered with BSCVA of 0.4 and refraction of ϩ6.00 Ϫ3.25 ϫ 82°. Corneal topography showed a discrete central fl attening of the surface with higher order aberrations that exceeded the mathematical capacities of the digital keratometer (Oculus Instruments, Wetzlar, Germany). The highly irregular microgeometry of the corneal surface appeared bipartite in two sections. A relative crater had formed around the center and to the edge of the fl ap, with an irregular peripheral rim. Ocular burning pain from postoperative dry eye syndrome persisted, which was of greater discomfort to the patient than the refractive fault. Slit-lamp examination showed a residual depression in the former place of the intracorneal lens with epithelial islets in the periphery of the interface. These signs gradually receded over 8 months postoperatively, with the central mark disappearing and lessening of dystopic epithelial and intrastromal opacities. Topographic readings confi rmed microscopic fl attening of the intracorneal lens footprint with marked higher order aberrations persisting. Tear fi lm secretion was severely impeded as noted with a 17-mm difference in Schirmer testing and patient complaints of persistent dry eye.
We report a case of uncomplicated LASIK for mild hyperopia without refractive improvement. Because repeat LASIK did not improve refraction, an intracorneal lens was implanted under the initial superfi cial fl ap. Recurrent lens decentration, presence of massive interface debris, and patient discomfort necessitated removal of the implant, which alleviated the optical problems but left the patient with lasting discomfort.
We cannot identify why the initial excimer laser procedure did not produce refractive correction, as the technical parameters were without diffi culty. We suggest that the subsequent intracorneal lens implantation 
